Photo of Andrew Arnold, MD

Andrew Arnold, MD

Murray-Heilig Chair in Molecular Medicine
Professor of Medicine and Genetics and Genome Sciences
Chief, Division of Endocrinology and Metabolism
Director, Center for Molecular Oncology and
Chief Academic Officer, Carole and Ray Neag Comprehensive Cancer Center
Director, Office of Physician-Scientist Career Development
NPI Number:
1003812520
Academic Office Location:
Center for Molecular Oncology
UConn Health
263 Farmington Avenue
Farmington, CT 06030-3101
Phone: 860-679-7640
Website(s):

Center for Molecular Oncology
Curriculum Vitae:
Education
No data available

Post-Graduate Training
TrainingInstitutionSpecialty
ResidencyUniversity of ChicagoInternal Medicine
FellowshipMassachusetts General HospitalMedicine, Endocrinology
FellowshipNational Cancer Institute/NIHMolecular Oncology

Awards
Name of Award/HonorAwarding Organization
Refer to Abbreviated CV Link

Parathyroid disorders; genetic/inherited endocrine tumor syndromes

The most longstanding interest of our laboratory has been in the molecular genetic underpinnings of tumors of the endocrine glands. It was in the context of a search for a parathyroid tumor oncogene lying adjacent to a clonal chromosomal breakpoint that we discovered cyclin D1 (PRAD1). Cyclin D1 has proven to play a key role in cell cycle regulation, and has emerged as a major human oncogene, important in multiple types of tumors including breast cancer and B-cell lymphoma. We are currently pursuing a number of approaches, including the use of transgenic mouse models, to learn more about the precise mechanisms by which cyclin D1 exerts its oncogenic effects. In addition to the cyclin D1 work, we are continuing a major initiative seeking additional genes that contribute to endocrine neoplasia. As an example, we identified the HRPT2 (CDC73) gene as a major factor in the development of malignant parathyroid tumors, a finding that carries important clinical implications.

please contact PI to discuss

Accepting Lab Rotation Students: YES

Journal Articles

Book Chapters

  • Gene test interpretation: MEN1 (multiple endocrine neoplasia).
    Arnold A, Newey P. Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc., 2023. 2023 Sep;
  • Multiple endocrine neoplasia type 1: clinical manifestations and diagnosis.
    Arnold A, Newey P. Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc., 2023. 2023 Sep;
  • Multiple endocrine neoplasia type 1: genetics.
    Arnold A, Newey P. Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc., 2023. 2023 Sep;
  • Multiple endocrine neoplasia type 1: management.
    Arnold A, Newey P. Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc., 2023. 2023 Sep;
  • Primary hyperparathyroidism: pathogenesis and etiology.
    El-Hajj Fuleihan G, Arnold A. Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc., 2023. 2023 Mar;
  • Parathyroid carcinoma.
    El-Hajj Fuleihan G, Arnold A. Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc., 2023.